Literature DB >> 16686789

Maternal psychological distress during pregnancy in relation to child development at age two.

Janet A DiPietro1, Matthew F S X Novak, Kathleen A Costigan, Lara D Atella, Sarah P Reusing.   

Abstract

Concern exists that a constellation of negative maternal emotions during pregnancy generates persistent negative consequences for child development. Maternal reports of anxiety, pregnancy-specific and nonspecific stress, and depressive symptoms were collected during mid-pregnancy and at 6 weeks and 24 months after birth in a sample of healthy women with low risk pregnancies. Developmental assessment and cardiac vagal tone monitoring were administered to 94 children at age 2. Higher levels of prenatal anxiety, nonspecific stress, and depressive symptoms were associated with more advanced motor development in children after postnatal control for each psychological measure; anxiety and depression were also significantly and positively associated with mental development. Mild to moderate levels of psychological distress may enhance fetal maturation in healthy populations.

Entities:  

Mesh:

Year:  2006        PMID: 16686789     DOI: 10.1111/j.1467-8624.2006.00891.x

Source DB:  PubMed          Journal:  Child Dev        ISSN: 0009-3920


  97 in total

1.  Challenges to bonnet monkey (Macaca radiata) social groups: Mother-infant dyad and infant social interactions.

Authors:  Mark L Laudenslager; C Natvig; S M Mikulich-Gilbertson; M Blevins; C Corcoran; P J Pierre; A J Bennett
Journal:  Dev Psychobiol       Date:  2010-07       Impact factor: 3.038

2.  Higher maternal prenatal cortisol and younger age predict greater infant reactivity to novelty at 4 months: an observation-based study.

Authors:  Elizabeth Werner; Yihong Zhao; Lynn Evans; Michael Kinsella; Laura Kurzius; Arman Altincatal; Laraine McDonough; Catherine Monk
Journal:  Dev Psychobiol       Date:  2012-07-06       Impact factor: 3.038

3.  A prospective study of maternal anxiety, perceived stress, and depressive symptoms in relation to infant cognitive development.

Authors:  Sarah A Keim; Julie L Daniels; Nancy Dole; Amy H Herring; Anna Maria Siega-Riz; Peter C Scheidt
Journal:  Early Hum Dev       Date:  2011-03-21       Impact factor: 2.079

4.  Prenatal antecedents of newborn neurological maturation.

Authors:  Janet A DiPietro; Katie T Kivlighan; Kathleen A Costigan; Suzanne E Rubin; Dorothy E Shiffler; Janice L Henderson; Joseph P Pillion
Journal:  Child Dev       Date:  2010 Jan-Feb

5.  The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development.

Authors:  Elysia P Davis; Curt A Sandman
Journal:  Child Dev       Date:  2010 Jan-Feb

6.  Mood disorders and their pharmacological treatment during pregnancy: is the future child affected?

Authors:  Catherine Monk; Elizabeth M Fitelson; Elizabeth Werner
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

Review 7.  Exposure to prenatal psychobiological stress exerts programming influences on the mother and her fetus.

Authors:  Curt A Sandman; Elysia P Davis; Claudia Buss; Laura M Glynn
Journal:  Neuroendocrinology       Date:  2011-04-15       Impact factor: 4.914

Review 8.  Research review: maternal prenatal distress and poor nutrition - mutually influencing risk factors affecting infant neurocognitive development.

Authors:  Catherine Monk; Michael K Georgieff; Erin A Osterholm
Journal:  J Child Psychol Psychiatry       Date:  2012-10-05       Impact factor: 8.982

9.  Prospective Relations Between Prenatal Maternal Cortisol and Child Health Outcomes.

Authors:  Michael E Roettger; Hannah M C Schreier; Mark E Feinberg; Damon E Jones
Journal:  Psychosom Med       Date:  2019 Jul/Aug       Impact factor: 4.312

10.  Antenatal and postnatal maternal mental health as determinants of infant neurodevelopment at 18 months of age in a mother-child cohort (Rhea Study) in Crete, Greece.

Authors:  Katerina Koutra; Leda Chatzi; Manolis Bagkeris; Maria Vassilaki; Panos Bitsios; Manolis Kogevinas
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-12-18       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.